Decision: Favourable

Decisions Table

Study Title:

Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous selatogrel for prevention of all-cause death and treatment of acute myocardial infarction in subjects with a recent history of acute myocardial infarction

  • NREC Code:

    22-NREC-CT-088

  • Decision:

    Favourable

  • Meeting Date:

    11/05/2022

  • Study Type:

    CT application

  • Principal Investigator:

    Dr Stephen O'Connor

  • PI Institution:

    St James's Hospital

  • Sponsor:

    Idorsia Pharmaceutical Ltd.

Scroll to Top